T1	DISO 1 21	Accidente bothrópico
T2	PROC 35 81	estudio multicéntrico de la eficacia seguridad
#1	AnnotatorNotes T2	C1096776; Multicenter Study; Research Activity + C0511730; Identify product efficacy and safety issues; Health Care Activity
T3	CHEM 105 127	antiveneno polivalente
#2	AnnotatorNotes T3	C0718591; Antivenin Polyvalent; Organic Chemical · Pharmacologic Substance
T4	CHEM 378 392	Antivipmyn-Tri
T5	CHEM 207 218	antivenenos
#3	AnnotatorNotes T5	C0003450; Antivenin; Immunologic Factor · Amino Acid, Peptide, or Protein · Pharmacologic Substance
T6	PROC 427 443	esquema de dosis
T7	PROC 305 339	evaluar la eficacia y la seguridad
#4	AnnotatorNotes T7	C0511730; Identify product efficacy and safety issues; Health Care Activity
T8	CHEM 346 376	antiveneno F(ab´)2 polivalente
T9	DISO 447 467	accidente bothrópico
T10	PROC 524 550	ensayo clínico-terapéutico
#5	AnnotatorNotes T10	C1515364; Therapeutic Clinical Trial; Research Activity
T11	DISO 1439 1461	implicaciones clínicas
T12	CHEM 573 579	veneno
#6	AnnotatorNotes T12	C0032346; Poisons; Hazardous or Poisonous Substance | C0042479; Venoms; Hazardous or Poisonous Substance
T13	CHEM 582 592	antiveneno
#7	AnnotatorNotes T13	C0003450; Antivenin; Immunologic Factor · Amino Acid, Peptide, or Protein · Pharmacologic Substance
T14	ANAT 593 599	sérico
#8	AnnotatorNotes T14	C0229671; Serum; Body Substance | C0588987; Serum product; Body Substance
T15	PROC 601 606	ELISA
#9	AnnotatorNotes T15	C0014441; Enzyme-Linked Immunosorbent Assay; Laboratory Procedure
T16	ANAT 764 770	sangre
#10	AnnotatorNotes T16	C0005767; Blood; Body Substance
T17	PROC 787 794	ingreso
#11	AnnotatorNotes T17	C0021629; Institutionalization; Health Care Activity | C0184666; Hospital admission; Health Care Activity
T18	DISO 811 819	sangrado
#12	AnnotatorNotes T18	C0019080; Hemorrhage; Pathologic Function
T19	DISO 843 851	sangrado
#13	AnnotatorNotes T19	C0019080; Hemorrhage; Pathologic Function
T20	DISO 881 895	envenenamiento
#14	AnnotatorNotes T20	C0032343; Poisoning; Injury or Poisoning | C0728899; Intoxication; Finding
T21	ANAT 1155 1162	séricas
#15	AnnotatorNotes T21	C0229671; Serum; Body Substance | C0588987; Serum product; Body Substance
T22	CHEM 1166 1172	veneno
#16	AnnotatorNotes T22	C0032346; Poisons; Hazardous or Poisonous Substance | C0042479; Venoms; Hazardous or Poisonous Substance
T23	PROC 1195 1206	tratamiento
#17	AnnotatorNotes T23	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T24	DISO 1225 1233	sangrado
#18	AnnotatorNotes T24	C0019080; Hemorrhage; Pathologic Function
T25	DISO 1376 1388	coagulopatía
#19	AnnotatorNotes T25	C0005779; Blood Coagulation Disorders; Disease or Syndrome
T26	DISO 1606 1614	secuelas
#20	AnnotatorNotes T26	C0543419; Sequela of disorder; Pathologic Function
T27	DISO 1393 1401	sangrado
#21	AnnotatorNotes T27	C0019080; Hemorrhage; Pathologic Function
T28	PROC 1713 1724	tratamiento
#22	AnnotatorNotes T28	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T29	DISO 672 680	mordidos
#23	AnnotatorNotes T29	C0037379; Snake Bites; Injury or Poisoning
T30	DISO 764 783	sangre incoagulable
T31	PROC 1541 1552	faboterapia
T32	CHEM 1669 1683	Antivipmyn-Tri
T33	CHEM 222 225	IgG
#24	AnnotatorNotes T33	C0020852; immunoglobulin G; Immunologic Factor · Amino Acid, Peptide, or Protein · Pharmacologic Substance
T34	DISO 1423 1434	antigenemia
T35	DISO 1498 1527	reacciones tempranas adversas
T36	DISO 1562 1569	muertes
#25	AnnotatorNotes T36	C1306577; Death (finding); Finding | C1546956; Patient Outcome - Died; Finding
T37	DISO 1729 1754	envenenamiento bothrópico
T38	CHEM 85 99	Antivipmyn-Tri
T39	CHEM 1069 1083	Antivipmyn-Tri
T40	PROC 553 569	cuantificaciones
T41	Duration 513 520	9 meses
T42	LIVB 614 623	pacientes
#26	AnnotatorNotes T42	C0030705; Patients; Patient or Disabled Group
T43	LIVB 655 664	pacientes
#27	AnnotatorNotes T43	C0030705; Patients; Patient or Disabled Group
T45	LIVB 685 699	Bothrops asper
#28	AnnotatorNotes T45	C0999141; Bothrops asper; Reptile
T46	LIVB 957 966	pacientes
#29	AnnotatorNotes T46	C0030705; Patients; Patient or Disabled Group
T47	Dose 1004 1013	5 frascos
T48	Duration 1237 1260	las primeras 6-12 horas
T49	PHYS 1294 1305	coagulación
#30	AnnotatorNotes T49	C0005778; Blood coagulation; Organ or Tissue Function
T50	Duration 1309 1317	24 horas
T51	Duration 1328 1336	48 horas
T52	Neg_cue 1389 1392	sin
T53	Neg_cue 1435 1438	sin
T54	LIVB 1468 1477	pacientes
#31	AnnotatorNotes T54	C0030705; Patients; Patient or Disabled Group
T55	Neg_cue 1554 1556	No
T56	LIVB 1580 1589	pacientes
#32	AnnotatorNotes T56	C0030705; Patients; Patient or Disabled Group
T44	LIVB 729 737	B. atrox
#33	AnnotatorNotes T44	C1622414; Fer-de-Lance; Reptile
T57	DEVI 1006 1013	frascos
#34	AnnotatorNotes T57	C0184301; Vial device; Medical Device
T58	Dose 1049 1051	10
T59	Duration 1176 1191	la primera hora
T60	DISO 1361 1372	recurrencia
#35	AnnotatorNotes T60	C2825055; Recurrence (disease attribute); Pathologic Function
T61	DISO 1407 1419	recurrencias
#36	AnnotatorNotes T61	C2825055; Recurrence (disease attribute); Pathologic Function
A1	Assertion T27 Negated
A2	Assertion T11 Negated
A3	Assertion T36 Negated
R1	Negation Arg1:T53 Arg2:T11	
R2	Negation Arg1:T52 Arg2:T27	
R5	Used_for Arg1:T8 Arg2:T6	
R6	Used_for Arg1:T4 Arg2:T6	
R10	Has_Duration_or_Interval Arg1:T10 Arg2:T41	
R11	Has_Duration_or_Interval Arg1:T40 Arg2:T41	
R12	Location_of Arg1:T14 Arg2:T40	
R13	Location_of Arg1:T14 Arg2:T15	
R14	Experiences Arg1:T42 Arg2:T40	
R15	Experiences Arg1:T42 Arg2:T12	
R16	Experiences Arg1:T42 Arg2:T13	
R17	Experiences Arg1:T42 Arg2:T15	
R18	Experiences Arg1:T43 Arg2:T29	
R19	Causes Arg1:T45 Arg2:T29	
R20	Causes Arg1:T44 Arg2:T29	
R21	Experiences Arg1:T43 Arg2:T30	
R22	Overlap Arg1:T30 Arg2:T17	
R24	Causes Arg1:T29 Arg2:T18	
R25	Causes Arg1:T29 Arg2:T19	
R26	Experiences Arg1:T43 Arg2:T18	
R27	Experiences Arg1:T43 Arg2:T19	
T62	Quantifier_or_Qualifier 820 825	local
#37	AnnotatorNotes T62	C0205276; Local; Spatial Concept
R28	Has_Quantifier_or_Qualifier Arg1:T18 Arg2:T62	
T63	Quantifier_or_Qualifier 852 861	sistémico
#38	AnnotatorNotes T63	C0205373; Systemic; Functional Concept
R29	Has_Quantifier_or_Qualifier Arg1:T19 Arg2:T63	
R30	Overlap Arg1:T18 Arg2:T17	
#39	AnnotatorNotes R30	(?)
R31	Overlap Arg1:T19 Arg2:T17	
#40	AnnotatorNotes R31	(?)
T64	Quantifier_or_Qualifier 900 904	leve
R32	Has_Quantifier_or_Qualifier Arg1:T20 Arg2:T64	
T65	Quantifier_or_Qualifier 920 928	moderado
R33	Has_Quantifier_or_Qualifier Arg1:T20 Arg2:T65	
T66	Quantifier_or_Qualifier 945 950	grave
#41	AnnotatorNotes T66	C1547227; Severe - Severity of Illness Code; Intellectual Product
R34	Has_Quantifier_or_Qualifier Arg1:T20 Arg2:T66	
R35	Experiences Arg1:T46 Arg2:T20	
T67	Quantifier_or_Qualifier 1029 1034	leves
T68	Quantifier_or_Qualifier 1037 1046	moderados
T69	Quantifier_or_Qualifier 1061 1067	graves
#42	AnnotatorNotes T69	C1547227; Severe - Severity of Illness Code; Intellectual Product
R36	Has_Dose_or_Strength Arg1:T39 Arg2:T58	
#43	AnnotatorNotes T58	[Dose expressed in vials]
R37	Has_Dose_or_Strength Arg1:T39 Arg2:T47	
R40	Used_for Arg1:T39 Arg2:T23	
T70	Observation 1106 1115;1135 1172	disminuir las concentraciones séricas de veneno
R39	Overlap Arg1:T70 Arg2:T59	
T71	Observation 1214 1233	detener el sangrado
R41	Overlap Arg1:T71 Arg2:T48	
R42	Causes Arg1:T39 Arg2:T70	
R43	Causes Arg1:T39 Arg2:T71	
T72	Observation 1280 1305	normalizar la coagulación
#44	AnnotatorNotes T72	C4539836; Normal coagulation; Finding
R44	Causes Arg1:T39 Arg2:T72	
R45	Overlap Arg1:T72 Arg2:T50	
R46	Overlap Arg1:T72 Arg2:T51	
R47	Overlap Arg1:T60 Arg2:T27	
R48	Overlap Arg1:T25 Arg2:T27	
R49	Overlap Arg1:T34 Arg2:T11	
R50	Overlap Arg1:T61 Arg2:T11	
R51	Experiences Arg1:T54 Arg2:T35	
T73	Quantifier_or_Qualifier 1529 1534	leves
R52	Has_Quantifier_or_Qualifier Arg1:T35 Arg2:T73	
R53	Causes Arg1:T31 Arg2:T35	
R54	Experiences Arg1:T56 Arg2:T26	
R55	Negation Arg1:T55 Arg2:T36	
R56	Used_for Arg1:T32 Arg2:T28	
#45	AnnotatorNotes T64	C2945599; Mild (qualifier value); Qualitative Concept
#46	AnnotatorNotes T65	C0205081; Moderate (severity modifier); Qualitative Concept
#47	AnnotatorNotes T68	C0205081; Moderate (severity modifier); Qualitative Concept
#48	AnnotatorNotes T67	C2945599; Mild (qualifier value); Qualitative Concept
#49	AnnotatorNotes T73	C2945599; Mild (qualifier value); Qualitative Concept
#50	AnnotatorNotes T6	C4684645; Dosage Regimen; Therapeutic or Preventive Procedure
A4	Experiencer T42 Patient
A5	Experiencer T43 Patient
A6	Experiencer T46 Patient
A7	Experiencer T54 Patient
A8	Experiencer T56 Patient
